Florentine E. F. Timmer

Amsterdam University Medical Centers

Papers

1

Total Citations

13

H-Index

1

About

Florentine E. F. Timmer is a pioneering translational researcher at the intersection of urologic oncology and cancer immunotherapy. Her primary research focuses on the immunomodulatory effects of focal therapies for prostate cancer, particularly irreversible electroporation (IRE). Timmer’s landmark work, the IRE-IMMUNO study, demonstrated that IRE of localized prostate cancer not only ablates tumors but also downregulates immune suppression and induces systemic anti-tumor T-cell activation—a finding with profound implications for combining focal therapy with immunotherapy. This prospective study, comparing IRE to robot-assisted radical prostatectomy, showed that IRE uniquely triggers a systemic immune response, potentially turning the tumor into an in situ vaccine. With 13 citations since its 2024 publication, this work has rapidly gained attention for redefining how we view local therapies in the era of immuno-oncology. Timmer’s contributions bridge the gap between surgical oncology and immunology, offering a paradigm shift where minimally invasive ablation may serve dual roles: tumor destruction and immune priming. Her research is essential reading for anyone interested in harnessing the immune system to improve outcomes in prostate cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti‐tumour T‐cell activation – <scp>IRE</scp> ‐ <scp>IMMUNO</scp> study
13 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Amsterdam University Medical Centers

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago